NCT00096109 2017-01-16
Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
National Cancer Institute (NCI)
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
Infinity Pharmaceuticals, Inc.
MedImmune LLC